Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)
Clinical trial NCT04254978 · COMPLETED
Trial details
- NCT number
- NCT04254978
- Sponsor
- Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2023-03-23
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.